Cargando…
Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
The mechanistic target of rapamycin (mTOR) is a kinase whose activation is associated with poor prognosis in pre-B cell acute lymphoblastic leukemia (B-ALL). These and other findings have prompted diverse strategies for targeting mTOR signaling in B-ALL and other B-cell malignancies. In cellular mod...
Autores principales: | Vo, Thanh-Trang, Herzog, Lee-or, Buono, Roberta, Lee, Jong-Hoon Scott, Mallya, Sharmila, Duong, Madeleine R., Thao, Joshua, Gotesman, Moran, Fruman, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569117/ https://www.ncbi.nlm.nih.gov/pubmed/34737376 http://dx.doi.org/10.1038/s41598-021-00950-y |
Ejemplares similares
-
mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL
por: Gotesman, Moran, et al.
Publicado: (2018) -
Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function
por: Chiu, Honyin, et al.
Publicado: (2021) -
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax
por: Herzog, Lee-or, et al.
Publicado: (2020) -
mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells
por: Beagle, Brandon R., et al.
Publicado: (2014) -
Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1
por: Mallya, Sharmila, et al.
Publicado: (2014)